Prothena unveils healthy volunteer safety data for Alzheimer's drug in Bristol Myers collab
A Big Pharma-partnered Alzheimer’s candidate is peeling back its first tranches of data.
Protein dysregulation outfit Prothena announced initial safety and …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
